Skip to main content
. 2012 Nov 30;109(51):20781–20782. doi: 10.1073/pnas.1218529110

Fig. 1.

Fig. 1.

Upper: Structures of LXA4 and AEA. Lower: Comparison of how an FAAH inhibitor (FAAH-I) and a CB1 receptor allosteric enhancer could affect the potency, efficacy, and selectivity with which endogenously released AEA targets cannabinoid CB1 receptors in the brain. Further details are provided in the text.